Martyna Giedrojc

Martyna Giedrojc is Director International Public Affairs and Professionals Relations Europe at Cepheid. Prior to her current role she has been working for London-based Public Affairs consultancies and advised clients on health policy issues. She is passionate about the societal value of medical technologies, digital health and innovation.

Martyna has almost a decade of relevant experience in healthcare and great understanding of European health systems. Through her career she has gained insights into country-level and EU policy making, while working in Brussels. She holds a Masters in Public Health and Healthcare Management from Medical University of Warsaw.

As Europe enters the fourth wave of COVID-19 and countries start to impose lockdown restrictions, we must not forget that we have the tools to tackle this. European society has undergone a profound transformation since the start of the COVID-19 pandemic. Testing has been placed at the heart of our health systems as one of the key solutions in tackling this crisis. Following the pandemic’s impact on our economy and wellbeing, health awareness has increased. We are able to quickly recognise COVID-19 symptoms and we know to get tested when needed. In fact, many of us test before visiting family; we test when going to a business meeting and for travelling. We now have a stronger appreciation of the impact that delayed diagnosis can have on our overall health. As we reflect on European Testing Week (22-29 November), it is clear to me that our efforts to raise awareness must go beyond the detection of chronic diseases and viral infections such as HCV, HBV and HIV. Testing is no longer just a part of health screening and prevention programmes. Testing supports the economy, saves lives and protects the most vulnerable in society. Testing can be accurate and fast The EU response to the COVID-19 pandemic put the spotlight on the importance of rapid diagnosis to prevent the spread of disease and enable patient monitoring. Many patients across Europe were offered testing in their community and in non-healthcare settings which enabled them to overcome barriers to accessing rapid testing. Patients can now have a rapid PCR test in near-patient settings (e.g., pharmacy, clinics, mobile units and airports) with the results within a one hour. [i] The time needed for the test results to come back does not compromise its sensitivity and accuracy when compared with results from traditional labs (which take...